Telecommunications Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecommunications Press Releases.

Press releases published on June 2, 2026

Jun. 2, 2026

Crescent Biopharma to Present at June Investor Conferences

Indeterminate GlobeNewswire

Jun. 2, 2026

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities

Indeterminate GlobeNewswire

Jun. 2, 2026

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results

Indeterminate GlobeNewswire

Jun. 2, 2026

Netskope Joins Anthropic’s Project Glasswing

Indeterminate GlobeNewswire

Jun. 2, 2026

Duos Technologies Receives $50.4 Million from APR Energy Asset Sale

Indeterminate GlobeNewswire

Jun. 2, 2026

Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution

Indeterminate GlobeNewswire

Jun. 2, 2026

Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults

Indeterminate GlobeNewswire

Jun. 2, 2026

BriaCell Therapeutics Announces Closing of Offering

Indeterminate GlobeNewswire

Jun. 2, 2026

MemeToro Launches AI-Powered Meme Market Infrastructure to Unite Creation, Trading, and Prediction Markets

Indeterminate GlobeNewswire

Jun. 2, 2026

TRREB Welcomes Launch of Ontario–Canada Development Charges Reduction Program

Indeterminate GlobeNewswire

Jun. 2, 2026

Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data

Indeterminate GlobeNewswire

Jun. 2, 2026

iBio to Participate in Upcoming Healthcare Investor Conferences

Indeterminate GlobeNewswire

Jun. 2, 2026

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Liberty Global Schedules Investor Call for Second Quarter 2026 Results

Indeterminate GlobeNewswire

Jun. 2, 2026

Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire